Citations (8)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (2)
Gene L Colice. (2008) Albuterol HFA for the management of obstructive airway disease. Expert Review of Respiratory Medicine 2:2, pages 149-159.
Read now
Read now
Hugh DC Smyth. (2005) Propellant-driven metered-dose inhalers for pulmonary drug delivery. Expert Opinion on Drug Delivery 2:1, pages 53-74.
Read now
Read now
Articles from other publishers (6)
Matteo Bonini, Corrado Di Mambro, Moises A Calderon, Enrico Compalati, Holger Schünemann, Stephen Durham & Giorgio W Canonica. (2013)
Beta
2
-agonists for exercise-induced asthma
. Cochrane Database of Systematic Reviews.
Crossref
Crossref
Gene Colice & William J. Calhoun. (2010) Section 2. Exercise-Induced Bronchospasm: Albuterol versus Montelukast. World Allergy Organization Journal 3:2, pages 23-30.
Crossref
Crossref
Leslie Hendeles, Gene L. Colice & Robert J. Meyer. (2007) Withdrawal of Albuterol Inhalers Containing Chlorofluorocarbon Propellants. New England Journal of Medicine 356:13, pages 1344-1351.
Crossref
Crossref
Felix S. F. Ram. (2012) Clinical Efficacy of Inhaler Devices Containing β2-Agonist Bronchodilators in the Treatment of Asthma. American Journal of Respiratory Medicine 2:4, pages 349-365.
Crossref
Crossref
Stephen J. Langley, Andrew P. Sykes, Elizabeth P. Batty, Catherine M. Masterson & Ashley Woodcock. (2002) A comparison of the efficacy and tolerability of single doses of HFA 134a albuterol and CFC albuterol in mild-to-moderate asthmatic patients. Annals of Allergy, Asthma & Immunology 88:5, pages 488-493.
Crossref
Crossref
Felix SF Ram, David DM Brocklebank, John White, John J Wright & Paul Jones. (2002) Pressurised metered dose inhalers versus all other hand-held inhaler devices to deliver beta-2 agonist bronchodilators for non-acute asthma. Cochrane Database of Systematic Reviews 2010:1.
Crossref
Crossref